A comprehensive view of Phase 3 Trial. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Late-stage biotechnology firm Orca Bio starts Phase 3 study of its cell therapy Orca-T in patients with acute myeloid leukemia, acute lymphocytic leukemia, high-risk myelodysplastic syndromes; study to enroll 174 patients at 20 transplant centers in US

Novavax starting Phase 2b/3 Hummingbird global clinical trial of its COVID-19 vaccine in children aged six months to 11 years old; trial to enroll 3,600 kids in US, Mexico, Europe, South America, Asia, Africa, with results by Q1 2023

FDA removes hold on Greenwich LifeSciences’ Phase 3 study of injectable GLSI-100 to treat breast cancer in patients with residual disease or who have high risk of disease returning; FDA placed initial hold due to manufacturing, pharmacy issues

Bristol Myers Squibb reports Phase 3 trials show early Zeposia ozanimod oral treatment improved or preserved cognitive function in patients with relapsing multiple sclerosis; MS affects 700,000 people in Europe, 2.5 million people globally

Sanofi to conduct Phase 3 clinical trial to evaluate subcutaneous vs intravenous administration of Isatuximab with Pomalidomide and Dexamethasone in adults with relapsed or refractory multiple myeloma; recruitment has not yet started

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count